ID

44452

Description

Improving Secretion of Insulin in New Onset Diabetes After Renal Transplantation; ODM derived from: https://clinicaltrials.gov/show/NCT01268995

Link

https://clinicaltrials.gov/show/NCT01268995

Keywords

  1. 9/23/21 9/23/21 -
Copyright Holder

Medical University of Vienna

Uploaded on

September 23, 2021

DOI

To request one please log in.

License

Creative Commons BY-NC 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility New Onset Diabetes Mellitus After Renal Transplantation NCT01268995

Eligibility New Onset Diabetes Mellitus After Renal Transplantation NCT01268995

Inclusion Criteria
newly diagnosed nodat defined by pathologic ogtt (2h, 75mg glucose): glucose ≥ 200mg/dl
defect in insulin secretion as judged by ogtt and homa b
renal transplantation (deceased or living donor) and treatment with the standard immunosuppression at our center, consisting of tacrolimus, mycophenolate mofetil, prednisone triple therapy without any induction
stable graft function for more than 3 months post transplant
informed consent of the patient
Exclusion Criteria
patients with prior history of type 1 or type 2 diabetes
time since transplantation more than 20 years
allergy against long-acting insulin or cyclosporine a
body mass index (bmi) > 35
pregnancy

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial